ߣߣÊÓƵ

Paris, 13 Oct 2005

The OECD Working Party on Biotechnology announced it will review what could best be done to advance the efficiency, utility and use of genomic knowledge for the delivery of safer medicinal products and better health. The announcement followed statements made by OECD Science and Health Ministers at their meetings in January and May 2004 that the challenge from increased understanding and use of human genetics had to be met in order to achieve the dual goals of economic growth and better public health. An OECD workshop on Pharmacogenetics is now set to take place in Rome, 17-19 October, 2005. The workshop should accomplish three main goals:

• Analyse and raise awareness on the extent of expected impacts on innovation and health care systems;
• Review and address regulatory issues and challenges that may arise in the context of pharmacogenetics;
• Identify and explore initiatives and frameworks relevant for pharmacogenetics development and implementation across OECD countries.

For further information, please contact us on: stibiotech@oecd.org

Organisation for Economic Co-operation and Development

Previous Item Back to Titles